Praxis Precision MedicinesÂ Inc (PRAX) Financials

$345.30

$-7.18 (-2.04%)

As on 09-Sep-2026 16:09EDT

Market cap

$9,823 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

7.4

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	--	--	8.55	2.45	1.46	--
Cost of Revenue	143.34	0.14	152.41	86.77	1.17	1.59
Gross Profit	-143.34	-0.14	-143.86	-84.32	-1.17	-1.59
Operating Expenses	234.86	326.06	56.31	42.05	214.99	167.33
Operating Profit (EBIT)	-378.17	-326.20	-200.17	-126.37	-214.99	-167.33
Other Income	--	--	--	--	0.96	0.27
Profit before Tax	-339.13	-303.27	-182.82	-123.28	-214.03	-167.06
Provision for Tax	--	--	--	0.26	-0.96	-0.18
Profit after Tax (Net Income)	-339.13	-303.27	-182.82	-123.28	-213.07	-166.88
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-214.03	-167.06

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	1,341.04	878.14	445.45	69.67	76.11	250.81
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	--	--	0.11	2.53	3.50	4.31
Current Liabilities	49.06	59.77	37.55	15.75	35.52	37.62
Total Liabilities	1,439.16	937.91	483.11	87.95	115.13	292.75

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	618.20	327.00	78.74	3.07	4.29	5.34
Current Assets	771.90	610.91	404.37	84.88	110.84	287.41
Total Assets	1,439.16	937.91	483.11	87.95	115.13	292.75
Total Debt*	1.09	0.11	1.37	2.50	4.51	4.31
Net Current Assets	722.85	551.14	366.82	69.13	76.50	248.98

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-249.07	-131.76	-111.14	-185.04	-124.55
Cash Flow from Investing Activities	--	-311.15	-248.49	38.95	96.89	-140.52
Cash from Financing Activities	--	702.17	514.32	91.87	10.47	107.59
Net Cash Inflow / Outflow	--	--	--	--	-77.69	-157.49

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-13.39	-13.48	-9.15	-13.61	-67.15	-55.67
Cash EPS ($)	--	-13.47	-9.13	-13.56	-67.02	-55.61
Adjusted Book Value ($)	--	39.02	22.29	7.69	23.99	83.67
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-11.07	-6.59	-12.27	-58.32	-41.55
Free Cash Flow per Share ($)	--	-11.07	-6.59	-12.27	-58.46	-41.90

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-45.77	-70.45	-161.38	-126.93	-61.43
ROE (%)	-30.56	-45.83	-70.98	-169.13	-130.35	-62.01
ROA (%)	-34.95	-42.68	-64.03	-121.41	-104.48	-56.01
EBIT Margin (%)	--	--	-2,137.48	-5,037.88	-14,684.84	--
Net Margin (%)	--	--	-2,137.48	-5,037.88	-8,800.99	-61,578.97
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	--	-1.00	2.50	0.67	--	--
EBIT Growth (%)	-35.10	-65.88	-48.30	42.66	-28.48	-170.03
Net Profit Growth (%)	-35.10	-65.88	-48.30	42.14	-27.68	-169.94
EPS Growth (%)	-8.99	-0.47	0.33	0.80	-0.21	-1.30
Book Value Growth (%)	144.56	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-21.87	-8.41	-1.64	-0.04	-0.35
Price / Book Value	7.36	7.55	3.45	2.90	0.10	0.24
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-6.86	-19.91	-6.28	-1.00	0.41	1.27
Close Price ($)	334.79	294.74	76.96	22.28	35.70	295.50
High Price ($)	366.52	317.72	86.93	283.50	309.00	914.27
Low Price ($)	37.19	26.70	20.50	11.85	22.20	190.65
Market Cap ($ Cr)	9,822.53	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.00	0.00	0.04	0.06	0.02
Short term debt to equity ratio	0.00	0.00	0.00	0.02	0.01	0.02
Current Ratio	15.73	10.22	10.77	5.39	3.12	7.64
Quick Ratio	15.73	--	--	--	--	--
Interest Coverage	--	--	--	--	-513.09	-919.41

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	0.03	0.02	0.01	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	48,468.68	21.98	43.12	3,969.40	1,703.43
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.